Latigo Biotherapeutics Inc. (LTGO) vs Odyssey Therapeutics, Inc. (ODTX)

A side-by-side comparison of Latigo Biotherapeutics Inc. and Odyssey Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LTGO

Latigo Biotherapeutics Inc.

$978M

$16.26HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

ODTX

Odyssey Therapeutics, Inc.

$871M

$18.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — LTGO vs ODTX

growth of $100 · dividends reinvested · last 1y

LTGO -7.6% (-7.6%/yr)ODTX -3.3% (-3.3%/yr)ODTX compounded faster over this window

LTGO ODTX

Metrics side by side

LTGO is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full LTGO analysis Full ODTX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.